(LIC) on Wednesday mentioned its shareholding in Divis Laboratories has crossed 5 per cent because it has bought extra shares for Rs 35.82 crore. mentioned its shareholding in Divis Laboratories has elevated from 4.992 per cent to five.032 per cent because the variety of shares held by it within the firm rose from 1,32,54,663 to 1,33,60,663.
Holding within the firm crossed the 5 per cent mark on November 7, 2022. The acquisition of shares was carried out at a mean worth of Rs 3,379.01, LIC mentioned in a regulatory submitting.
As a regulatory disclosure norm, listed corporations are required to tell the inventory exchanges upon change in shareholding to the tune of 5 per cent and above.
Divis Laboratories is engaged in manufacturing of Active Pharmaceutical Ingredients (APIs), intermediates and nutraceutical components with predominance in exports.
Inventory of LIC closed at Rs 631.20 apiece on BSE, down by 0.33 per cent, whereas Divis Lab scrip ended 3.38 per cent decrease at Rs 3,298.15
